17th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
March 18-20, 2018 • Denver, CO
| Assessing the Implementation of the Pennsylvania Newborn Hearing Screening Program
Assessing the Implementation of the Pennsylvania Newborn Hearing Screening Program
Pennsylvania’s Newborn Hearing Screening program is a successful state-run program that is generally meeting the goals of early identification of children with hearing loss. Through the recommendations of Joint Committee on Infant Hearing (JCIH), children must be screened for hearing loss by one month of age. This session will discuss a retrospective study of data collected through the Center of Disease Control and Prevention (CDC) from 2000 to 2014, assessing Pennsylvania’s Early Hearing Detection and Intervention Program. Descriptive information on the percent of children screened within the state, children who were not screened, and the outcomes of those screened will be discussed along with the implication of the statistics collected. From the outcomes, diagnostic outlook and early intervention are analyzed to provide a broad visualization of the impact of early identification. Current affairs and the impact on future implications of the Early Hearing Detection and Intervention and in the state will be further discussed. Following this session, attendants will have a better understanding of the longitudinal growth of the Newborn Hearing Screening program in the state of Pennsylvania and have a stronger grasp on the importance of early identification of hearing impairment nationally,
- Following this session, the attendee will be able to describe the history of the Newborn Hearing Screening in Pennsylvania
- Following this session, the attendee will be able to summarize the growth in newborns screened over time
- : the attendee will develop an awareness of current affairs and their impact on the future of Newborn Hearing Screening programs in the state of Pennsylvania and across the country.
Presentation:
This presentation has not yet been uploaded or the speaker has opted not to make the presentation available online.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Aaron Roman
(), West Chester University, aroman@wcupa.edu;
Aaron Roman is an assistant professor in Communication Science and Disorders at West Chester University, where he teaches courses in hearing disorders and supervises graduate clinical education for hearing. His research interests include the effects of reduced audibility on cognitive processing, hearing healthcare economics and advocacy, and clinical education.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Diane Sabo
(), NCHAM, dsabo@audiologysystems.com;
Dr. Sabo serves in a position at Otometrics/Audiology Systems that was formed two years ago to analyze and develop markets for hearing assessment and screening products Previously, she has had over 25 years of clinical work with infants and children, particularly in the area of the electrophysiologic evaluation of the auditory system, including both screening and diagnostics. Her research interest is in the area of the physiologic evaluation of infants and children using evoked potentials and otoacoustic emissions with special emphasis on the screening of newborns for hearing loss. Additionally, Dr. Sabo has held various managerial positions at Children’s Hospital of Pittsburgh of UPMC, including Coordinator of the Auditory Evoked Potentials and Newborn Hearing Screening Programs and ultimately as Director of Audiology and Speech-Language Pathology. As Director, the following were the major responsibilities
o Oversight of all administrative, service delivery, education and research activities within the Department of Audiology and Speech-Language Pathology
o Responsible for the day-to-day administrative and clinical activities within the Department of Audiology and Speech-Language Pathology
o Hiring and performance evaluations of staff members in the Department of Audiology and Speech-Language Pathology—86 employees
o Responsible for establishing productivity standards, preparing budgets and tracking of revenues and expenses throughout a given budget year with an operating budget of over $4.7 million and revenues of approximately $21 million.
Dr. Sabo has had numerous publications and presentations and continues to serve on committees for national association and consults for several NIH grants on cytomegalovirus (CMV), a major cause of hearing loss in infants and children
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.